logo BDSP

Base documentaire


  1. Using appropriate comparisons in economic evaluations : An exercise in belgium.

    Article - En anglais

    This paper considers standard effective treatments for non-Hodgkin's lymphoma and early breast cancer in premenopausal women.

    The literature assesses the treatments'effectiveness, and expected charges for different treatments in the context of the Belgian Health Insurance System are compared.

    Ovariectomy in breast cancer (770 ECU) and conventional chemotherapy in non-Hodgkin (2,745 lymphoma ECU) prove equally effective and are less costly in comparison with chemotherapy (1,904 ECU) in breast cancer or chemotherapy and autologous bone marrow transplantation (19,262 ECU) in non-Hodgkin's lymphoma.

    Further unbiased insights in competitive treatments'costs and outcome could save money and enhance developments in cancer care.

    Mots-clés Pascal : Belgique, Europe, Tumeur maligne, Glande mammaire, Stade précoce, Lymphome non hodgkinien, Homme, Femelle, Période activité génitale, Economie santé, Analyse coût efficacité, Cancérologie, Système santé, Protocole thérapeutique, Assurance maladie, Evaluation, Glande mammaire pathologie, Hémopathie maligne, Lymphoprolifératif syndrome, Registre spécifique

    Mots-clés Pascal anglais : Belgium, Europe, Malignant tumor, Mammary gland, Early stage, Non Hodgkin lymphoma, Human, Female, Sexually active period, Health economy, Cost efficiency analysis, Cancerology, Health system, Therapeutic protocol, Health insurance, Evaluation, Mammary gland diseases, Malignant hemopathy, Lymphoproliferative syndrome

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 99-0343970

    Code Inist : 002B30A01B. Création : 14/12/1999.